Latest news with #Drugs
Yahoo
4 hours ago
- Business
- Yahoo
Protein Drugs Analysis Report 2025-2029: Therapeutic Proteins Gain Traction for Targeted, Low-Toxicity Treatments, Competitive Landscape Intensifies as Leading Firms Expand Investments
The Protein Drugs Market, valued at USD 441.7 billion in 2024, is set to reach USD 655.7 billion by 2029, growing at an 8.2% CAGR. The report covers market trends, technologies, regional insights, and company profiles, highlighting the rise of recombinant protein drugs for treating diseases like cancer and diabetes. Protein Drugs Market Dublin, June 10, 2025 (GLOBE NEWSWIRE) -- The "Protein Drugs Market 2025" report has been added to Protein Drugs Market was valued at USD 441.7 Billion in 2024, and is projected to reach USD 655.7 Billion by 2029, rising at a CAGR of 8.2% The report analyzes trends in the global market for protein drugs and manufacturing technologies. The report includes global revenue ($ millions) for the base year of 2023 and estimated data for the forecast period of 2024 through 2029. The market is segmented by product type/subtype, manufacturing technology and region. The regions covered are North America, Europe, Asia-Pacific and the Rest of the World, focusing on major countries in these regions. Therapeutic proteins are a class of medicines that help treat a number of indications, such as cancer, diabetes, stroke, anemia and hemophilia. Protein drugs perform particular and complex functions compared to small molecules. Due to the high specificity, these protein drugs are less toxic and less likely to interfere with normal biological processes. Protein drugs can be manufactured in many ways, but most proteins are produced through recombinant deoxyribonucleic acid (rDNA) technology, using bacteria, yeast or mammalian cells as the host report focuses on the trends and challenges that affect the market and the vendor landscape. It analyzes environmental, social, and corporate governance (ESG) developments and discusses patents and emerging technologies related to the market. The report concludes with an analysis of the competitive landscape, which provides the rankings and market shares of leading companies in the protein drug market. It also has a section of company profiles that shows financials, product portfolios and recent report includes: 79 data tables and 57 additional tables An analysis of the global markets for protein drugs and their manufacturing technologies Analyses of the global market trends, with revenue data for 2021 to 2023, estimates for 2024, and projected CAGRs through 2029 Estimates of the size of and revenue prospects for the global market, along with a market share analysis by type of protein drug, manufacturing technology, and region Facts and figures pertaining to the market dynamics, technological advances, regulations, and the impact of macroeconomic factors Insights derived from the Porter's Five Forces model, as well as global supply chain and PESTLE analyses Analysis of the advances in manufacturing technologies, disease prevalence trends, new products, and the impact of biosimilars entering the market for protein drugs An analysis of patents and significant patent grants Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook Profiles of leading companies, including: AbbVie Inc., Bristol Myer Squibb, Merck & Co., Novo Nordisk S/A, Sanofi, and Roche Key Attributes: Report Attribute Details No. of Pages 162 Forecast Period 2024 - 2029 Estimated Market Value (USD) in 2024 $441.7 Billion Forecasted Market Value (USD) by 2029 $655.7 Billion Compound Annual Growth Rate 8.2% Regions Covered Global Key Topics Covered: Chapter 1 Executive Summary Market Outlook Scope of Report Market Summary Chapter 2 Market Overview Current and Future Market Overview Technology Background Pharmacological Classification of Therapeutic Proteins Protein Therapeutics with Enzymatic or Regulatory Activity Protein Therapeutics with Special Targeting Activity Protein Vaccines Characteristics of Therapeutic Proteins Macroeconomic Factors Porter's Five Forces Analysis Supply Chain Analysis R&D Manufacturing Packaging Wholesale Distributors and Repackagers Pharmacies/Hospitals Dispensed to Consumers Chapter 3 Market Dynamics Global Market Dynamics Market Drivers Advances in Manufacturing Technologies Continuous Product Launches Increasing Incidence of Cancer Market Restraints High Costs of Protein Drugs Complex Regulatory Procedures Market Challenges Patent Expiration and Loss of Exclusivity Protein Drugs Stability and Delivery Market Opportunities Increasing Number of Approvals for MAbs Licensing and Collaboration Agreements Chapter 4 Regulatory Landscape Regulatory Scenario Price Regulations Chapter 5 Emerging Technologies Overview Emerging Technologies in Protein Drugs Market Bispecific Antibodies and Multi-Specific Antibodies Antibody-Drug Conjugates Antibody Fusion Proteins AI in the Protein Drug Market Chapter 6 Market Segment Analysis Overview Segmentation Breakdown Global Market for Protein Drugs, by Type MAbs Peptide Hormones Vaccines Blood Factors Cytokines Therapeutic Enzymes Peptide Antibiotics Fusion Proteins Global Market for Protein Drugs, by Manufacturing Technology Cell Culture Microbial Fermentation Natural Source Embryonated Egg Chemical Synthesis Transgenics Market Breakdown by Region Global Market for Protein Drugs, by Region North America Europe Asia-Pacific Rest of the World Chapter 7 Competitive Intelligence Industry Structure Leading Protein Drugs, 2023 Market Share Analysis MAbs Peptide Hormones Strategic Analysis Acquisitions Product Approvals Agreements and Partnerships Other Strategies Chapter 8 Sustainability in the Protein Drug Market: ESG Perspective Sustainability in the Protein Drug Industry ESG Risk Ratings: Understanding the Data ESG Performance Analysis Environmental Performance Social Performance Governance Performance Concluding Remarks Companies Featured AbbVie Inc. Amgen Inc. Astrazeneca Bayer AG Bristol-Myers Squibb Co. F. Hoffmann-La Roche Ltd. Johnson & Johnson Services Inc. Lilly Merck & Co. Inc. Novartis AG Novo Nordisk A/S Pfizer Inc. Regeneron Pharmaceuticals Inc. Sanofi Takeda Pharmaceutical Co. Ltd. For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Protein Drugs Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Yahoo
2 days ago
- Health
- Yahoo
Three Big Medical Costs That Retirees Often Underestimate
Drugs, remote locations and concierge care can add tens of thousands of dollars to healthcare costs in retirement.
Irish Independent
6 days ago
- Health
- Irish Independent
Cork pharmacies sign up for free HRT scheme of ‘transformational' potential to women's health
HRT is a medicine-based treatment used to relieve symptoms of menopause and perimenopause. Most pharmacies in Cork and nationwide have signed up to participate in the scheme, with the numbers increasing daily. Cork North West TD John Paul O'Shea said 208 pharmacies in Cork will offer the free medication to women, which is 'extremely positive.' 'The majority of pharmacies across the country are now participating in the scheme, and this figure is increasingly daily, meaning that all women will be able to access this free medication in a pharmacy convenient for them. 'In Cork, already 208 pharmacies will offer the free medication to women, which is extremely positive. 'It's important to note that the new arrangement includes a pharmacy dispensing fee, so medication will be completely free,' he said. Minister for Health Jennifer Carroll MacNeill was commended by her party colleague Mr O'Shea, who said he was 'grateful' to the Minister for her role in the scheme. 'The symptoms women encounter during perimenopause and menopause are varied and women's lives can be hugely impacted 'HRT is such an important medicinal regime for women and can positively improve their lives and make daily living much easier. 'This scheme is transformational for women. 'I commend the pharmacies in Cork who have joined the scheme to continue to provide vital healthcare for their communities,' concluded Mr O' Shea. Women who have been private patients and who wish to avail of this will need to possess a Drugs Payment Scheme (DPS) card. Medical card holders can continue to access HRT medication as normal – a DPS card is not necessary. Women can find their nearest pharmacy to them that is providing the service via:
BBC News
22-05-2025
- BBC News
Attempted murder arrests after man shot in head in West Bromwich
Two people have been arrested on suspicion of attempted murder after a man was victim, in his 20s, suffered gunshot wounds to his head and shoulder after a vehicle was fired at on Trinity Way shortly after 11:30 BST on 1 was treated for his injuries in hospital and was later discharged, West Midlands Police said.A force spokesperson said seven people were arrested on Tuesday evening in connection with the shooting and class A drugs were also recovered. Two men from West Bromwich, aged 21 and 22, were arrested on suspicion of attempted murder while another two from the town, aged 26 and 44, were arrested on suspicion of possessing a knife in a public men from Birmingham, aged 20, 21 and 22, were arrested on suspicion of conspiring to supply class A drugs and assisting an offender. Follow BBC Birmingham on BBC Sounds, Facebook, X and Instagram.
CTV News
21-05-2025
- CTV News
Man charged after stealing vehicle with child inside: London police
A Maidstone, Ont. man remains in custody after police say he stole a vehicle with a child in the backseat in the south end of city last week. Shortly after 3:30 p.m. on Friday, a woman called 911 to report as she was placing her child into the back seat of her car in the area of Colonel Talbot Road and Burtwistle Lane, an unknown male entered the driver's seat and stole the vehicle. The suspect stopped the vehicle a short distance away after seeing the child was still inside. Police say the victim was able to get her child out of the car before the man fled the area in the stolen vehicle at a high rate of speed. Officers responding learned as the vehicle fled the area, the suspect male driver almost caused several collisions. Police located the vehicle in the 6000 block of Colonel Talbot Road after receiving a report of a single vehicle collision into a ditch. Officers arrived and located the suspect exiting the vehicle. Police attempted to arrest the man when he fled from officers on foot. The suspect was arrested a short distance away. Police say a search of the man yielded a quantity of drugs. No injuries were reported. As a result of the investigation, a 35-year-old Maidstone man has been charged with the following offences: Theft of a motor vehicle; Kidnapping; Two (2) counts of dangerous operation of a motor vehicle; Resist arrest; Impaired exceed blood drug concentration; and, Possession of a Schedule I substance. The accused remains in custody and scheduled to reappear in London court today in relation to the charges. Anyone with information in relation to this incident is asked to call the London Police Service at (519) 661-5670 or Crime Stoppers at 1-800-222-TIPS (8477). Information can also be sent in online anonymously to London Middlesex Crime Stoppers.
